Tag: Drug
Viatris’ VR-205 Shows Strong Phase 3 Results in Japanese IgA Nephropathy Patients
Viatris Inc. (Nasdaq: VTRS) - reported encouraging top-line data from a Phase 3 trial of VR-205, a targeted-release budesonide therapy marketed elsewhere as Tarpeyo and Kinpeygo, in Japanese adults living...
Aurobindo Pharma USA Secures FTC Nod for Lannett Company Acquisition Deal
Aurobindo Pharma USA, Inc. (“Aurobindo USA”), a wholly owned subsidiary of the Aurobindo Pharma Limited, earlier in this week had announced that it has received approval from the U.S. Federal...
Lupin Secures U.S. FDA Tentative Approval for Enzalutamide Tablets
Lupin Limited (Lupin) the Mumbai, India based global pharma major earlier this week had announced that the company has received tentative approval from the...
Mayo Clinic Finds Common Surgical Drug Could Reduce Risk of Liver Failure
Researchers at Mayo Clinic and Michigan State University have uncovered a potentially life-saving application for tranexamic acid, a widely used clot-preserving medication, in the context of...
Shilpa Biologicals Activates GMP-Certified ADC Manufacturing Hub in Dharwad, India
Shilpa Biologicals, the biologics arm of Raichur-based Shilpa Medicare Ltd., has formally activated its antibody–drug conjugate (ADC) drug substance manufacturing facility in Dharwad, India. The plant is currently...
New Hope for Thyroid Eye Disease Treatment as FDA Approves Lumvoa
Waltham-based Viridian Therapeutics (Nasdaq: VRDN) has secured U.S. Food and Drug Administration clearance for Lumvoa™ (veligrotug-vvze), marking the company's debut as a commercial-stage biotech and...